CAMP
CAMP4 THERAPEUTICS CORPORATION Healthcare - Biotechnology Investor Relations →
CAMP4 THERAPEUTICS CORPORATION (CAMP) closed at $5.00 as of 2026-03-20, trading 18.4% above its 200-week moving average of $4.22. The stock is currently moving closer to the line, down from 28.4% last week. The 14-week RSI sits at 37, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.40 ratio) is neutral — neither side is clearly dominating.
Over the past 27 weeks of data, CAMP has crossed below its 200-week moving average 3 times. On average, these episodes lasted 4 weeks.
With a market cap of $259 million, CAMP is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -145.1%. The stock trades at 5.4x book value.
Share count has increased 3.4% over three years, indicating dilution.
In the past 12 months, corporate insiders have made 7 open-market purchases totaling $15,563,424. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Historical Touches
CAMP has crossed below its 200-week MA 3 times
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2025 | Oct 2025 | 6 | 44.9% | N/A | +119.3% |
| Nov 2025 | Dec 2025 | 3 | 28.3% | N/A | +72.4% |
| Jan 2026 | Feb 2026 | 4 | 11.9% | N/A | +24.7% |
Frequently Asked Questions
Is CAMP below its 200-week moving average?
No. CAMP4 THERAPEUTICS CORPORATION (CAMP) is currently 18.4% above its 200-week moving average of $4.22. It would need to fall to $4.22 to cross below the line.
What is CAMP's 200-week moving average price?
CAMP4 THERAPEUTICS CORPORATION's 200-week moving average is $4.22 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CAMP drops below its 200-week moving average?
CAMP has crossed below its 200-week moving average 3 times in our data. These episodes lasted 4 weeks on average.
Is CAMP a good value right now?
Here's what our data says about CAMP as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 37. Free cash flow is currently negative. Return on equity is -145.1%. Price-to-book is 5.4x. This is not a buy or sell recommendation — always do your own research.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20